IL17A and familial hypercholesterolemia: CH reduces hypercholesterolemia-mediated atherosclerosis via modulating the inflammatory genes expression including TNF-α, toll-like receptors (TLR4), IL-17, and NLRP3 in the intestine and aorta compared with hypercholesterolemia control rats [52].